This discrepancy is just not shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have comparable or greater potencies than copyright as dopamine reuptake inhibitors. These findings have evoked a hypothesis that copyright may additionally operate to be a so-termed "DAT inverse agonist" or "unfavo